Medtronic (MDT) Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
Go back to Medtronic (MDT) Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic Stenosis| Medtronic Inc. (NYSE: MDT) | Delayed: 94.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $94.17 | 52 Week High | $89.27 | |||
| Open | $94.17 | 52 Week Low | $71.03 | |||
| Day High | $94.17 | P/E | 26.75 | |||
| Day Low | $94.17 | EPS | $3.52 | |||
| Volume | 2,386 | |||||

